Endocrinology, Vol 118, 2300-2304, Copyright © 1986 by Endocrine Society

ARTICLES

Hypercalcemia inhibits the rapid stimulatory effect on calcium transport in perfused duodena from normal chicks mediated in vitro by 1,25-dihydroxyvitamin D3

Y Yoshimoto, I Nemere and AW Norman

We have previously reported that vascular perfusion of normal vitamin D3-replete chick duodena with physiological amounts of 1,25- dihydroxyvitamin D3 [1,25-(OH)2D3] increases the movement of 45Ca2+ from the lumen to the venous effluent within 14 min under conditions of normal Ca2+ (0.9 mM) concentration in both the lumen and vascular perfusate. The present studies were designed to further explore details of this rapid 1,25-(OH)2D3 effect as a function of seco-steroid concentration and under conditions where the free Ca2+ concentrations in the perfusate were varied from 0.54-1.26 mM. Concentrations of 1,25- (OH)2D3 in the vascular perfusate ranging from 30-650 pM elicited an increasing stimulation of Ca transport, as judged by 45Ca levels in the venous effluent. At 0.98-6.5 nM 1,25-(OH)2D3, progressive inhibition of Ca transport was observed, yielding a biphasic dose-response curve. The optimal concentration of 650 pM 1,25-(OH)2D3 was used in subsequent experiments designed to study the effects of vascular Ca2+ levels on 45Ca transport mediated by the seco-steroid. The basal Ca2+ transport ratio, in the absence of 1,25-(OH)2D3, did not change when the divalent cation of the vascular perfusate was varied over the range 0.54-1.26 mM free calcium. However, the effect of 1,25-(OH)2D3 on 45Ca2+ transport was completely abolished in the group treated with 1.21 mM Ca2+ in the perfusate, but not in the groups treated with concentrations less than 1.17 mM Ca2+. These results suggest that the rapid intestinal calcium transport response to 1,25-(OH)2D3 may be modulated locally in part by the prevailing ionized Ca concentration of the vascular perfusate.

This article has been cited by other articles:

				A. W. Norman Vitamin D Receptor: New Assignments for an Already Busy Receptor Endocrinology, December 1, 2006; 147(12): 5542 - 5548. [Abstract] [Full Text] [PDF]

				A. W. Norman, W. H. Okamura, M. W. Hammond, J. E. Bishop, M. C. Dormanen, R. Bouillon, H. van Baelen, A. L. Ridall, E. Daane, R. Khoury, et al. Comparison of 6-s-cis- and 6-s-trans-Locked Analogs of 1{alpha},25-Dihydroxyvitamin D3 Indicates That the 6-s-cis Conformation Is Preferred for Rapid Nongenomic Biological Responses and That Neither 6-s-cis- nor 6-s-trans-Locked Analogs Are Preferred for Genomic Biological Responses Mol. Endocrinol., September 1, 1997; 11(10): 1518 - 1531. [Abstract] [Full Text]

				K. Takeuchi and S. E. Guggino 24R,25-(OH)2 Vitamin D3 Inhibits 1alpha ,25-(OH)2 Vitamin D3 and Testosterone Potentiation of Calcium Channels in Osteosarcoma Cells J. Biol. Chem., December 27, 1996; 271(52): 33335 - 33343. [Abstract] [Full Text] [PDF]